GC
ARA

Guggenheim Capital’s American Renal Associates Holdings, Inc ARA Stock Holding History

Guggenheim Capital’s Portfolio ARA Stock Details ARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-47,040
Closed -$539K – 2201
2020
Q4 		$539K Buy
+47,040
New +$536K ﹤0.01% 1606

Guggenheim Capital's ARA Position: Q1 2021 in Review

Guggenheim Capital sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2021, closing a stake of 47,040 shares — an estimated $539K sold.

Guggenheim Capital first reported a position in ARA in Q4 2020 and held it in 1 quarter. The position peaked at $539K in Q4 2020. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.

  • Guggenheim Capital reported no remaining American Renal Associates Holdings, Inc position as of Q1 2021 after selling out during the quarter.
  • Guggenheim Capital sold 47,040 American Renal Associates Holdings, Inc shares in Q1 2021, an estimated $539K.
  • Guggenheim Capital first reported a position in American Renal Associates Holdings, Inc in Q4 2020 and held it in 1 quarter.
  • Guggenheim Capital's American Renal Associates Holdings, Inc position peaked at $539K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2021.

Based on Guggenheim Capital's 13F filing for Q1 2021, filed 13 May 2021.